Taysha Gene Therapies, Inc. (TSHA)
5.49
-0.05
(-0.90%)
USD |
NASDAQ |
May 22, 16:00
5.49
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies EPS Diluted (Quarterly) : -0.1157 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| United Therapeutics Corp. | 5.824 |
| TG Therapeutics, Inc. | 0.1236 |
| ADMA Biologics, Inc. | 0.1889 |
| UroGen Pharma Ltd. | -0.4698 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.41M |
| Total Expenses (Quarterly) | 42.41M |
| Enterprise Value | 1.369B |
| Earnings Yield | -7.22% |
| Normalized Earnings Yield | -6.920 |